PolyPeptide Group News and Resources

CDMO News

PolyPeptide Group Begins Large-Scale SPPS Production at Belgian Facility

PolyPeptide Group AG , a global CDMO specialising in peptide-based active pharmaceutical ingredients, has announced the commencement of production at its newly commissioned solid-phase peptide synthesis (SPPS) capacity in Braine-l’Alleud, Belgium. The €100 million facility represents the largest single investment

20 December 2024

PolyPeptide Group

PolyPeptide Group is a Manufacturer/Innovator company operating in the pharmaceutical industry. PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical

27 November 2023

Welcome to PharmaSource

Join the global community of outsourcing & procurement professionals from the world’s leading pharma and biotechs:

Stay ahead of trends and best practices

Exclusive downloads and podcasts

Get invites to special events and meetups

Sign up for your free membership

PolyPeptide Group News and Resources

PolyPeptide Group Begins Large-Scale SPPS Production at Belgian Facility

PolyPeptide Group

Welcome to PharmaSource

Follow us

Top Links

Get in touch

Who do you rate?

Recommend a Supplier